LOS ANGELES--(BUSINESS WIRE)--Jan. 4, 2005--Donald R. Wesson, M.D., a prominent clinician and investigator in the field of addiction, has been named Vice President of Scientific Affairs for Hythiam, Inc. (AMEX:HTM), a healthcare services management company that delivers to treatment providers both proprietary administrative services and physiological protocols designed to treat addiction. Dr. Wesson has been the principal investigator for more than 20 clinical trials sponsored by the National Institute on Drug Abuse (NIDA) or the pharmaceutical industry. He has been extensively published, authoring or co-authoring more than 100 articles, book chapters, books and monographs on addiction.
